fig1

Impact of previous anti-angiogenesis treatment in nivolumab-treated advanced non-small cell lung cancer

Figure 1. Progression-free survival according to clinical characteristics. Progression-free survival curves were plotted according to six clinical characteristics. log-rank tests were used for statistical analysis